Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, June 27, 2023
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
[ Tue, Jun 27th 2023
] - WOPRAI
Joon Lee Reiterated (VRNA) at Strong Buy and Held Target at $32 on, Jun 27th, 2023
Joon Lee of Truist Securities, Reiterated "Verona Pharma plc" (VRNA) at Strong Buy and Held Target at $32 on, Jun 27th, 2023.
Joon has made no other calls on VRNA in the last 4 months.
There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Joon's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joon
- Edward Nash of "Canaccord Genuity" Maintained at Sell with Increased Target to $33 on, Wednesday, May 10th, 2023
- Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $31 on, Monday, March 20th, 2023
